Anticancer drugs: A double strike at kinases

Nature Reviews Drug Discovery

Volumn 9, Issue 4, 2010, Pages 270-271

  Harrison, Charlotte ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; B RAF KINASE; B RAF KINASE INHIBITOR; ENZYME INHIBITOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR INHIBITOR; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; ARTICLE; DRUG POTENCY; DRUG TARGETING; PRIORITY JOURNAL; PROTEIN TARGETING; PUBLICATION;

EID: 77950509855     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd3152     Document Type: Article

References (1)

1. ORIGINAL RESEARCH PAPER Murphy, E. A. et al. Disruption of angiogenesis and tumor growth with an orally active drug that stabilzes the inactive state of PDGFRβ/B-RAF. Proc. Natl Acad. Sci. USA 107, 4299-4304 (2010)